Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Clin Imaging. 2023 Sep 16;104:109984. doi: 10.1016/j.clinimag.2023.109984

Table 1.

showing the difference in characteristics between benign and malignant lung nodules.

Benign resections (n=38) Malignant resections (n=100) P-value
Patient Sex Male 20 (53%) 44 (44%) 0.2
Female 18 (47%) 56 (56%)
Patient Age Median 65 66 0.3
Range 58–80 55–78
Nodule Size Median 13 14 0.4
Range 4–41 5–66
Nodule Type Ground glass 2 (5%) 11 (11%) 0.3
Part Solid 10 (26%) 34 (34%)
Solid 26 (68%) 55 (55%)
Spiculated Nodule Yes 15 (39%) 39 (39%) 0.6
No 23 (61%) 61 (61%)
Lung-RADS 2 4 (11%) 1 (1%) 0.02
3 2 (5%) 5 (5%)
4A 11 (29%) 23 (23%)
4B 13 (34%) 26 (26%)
4X 8 (21%) 45 (45%)
Nodule status: Baseline 7 (18%) 27 (27%) 0.3
Stable 3 (8%) 12 (12%)
New 9 (24%) 12 (12%)
Growing 19 (50%) 49 (49%)
FDG-uptake if PET/CT done: None 2 (11%) 7 (9%) 0.12
Mild 10 (53%) 19 (25%)
Moderate 3 (16%) 20 (26%)
Intense 4 (21%) 30 (39%)
Pre-operative Biopsy Yes 4 (11%) 19 (19%) 0.18
No 34 (89%) 81 (81%)
Brock calculator category: Very low (<5% risk) 9 (24%) 8 (8%) 0.03
Low-Moderate (5–65% risk) 27 (71%) 88 (88%)
High (>65% risk) 2 (5%) 4 (4%)

Wilcoxon test was used for the p-values of patients age and nodule size.